Literature DB >> 19363666

Role of extracellular signal-regulated kinase for endothelial progenitor cell dysfunction in coronary artery disease.

Erik B Friedrich1, Christian Werner, Katrin Walenta, Michael Böhm, Bruno Scheller.   

Abstract

In patients with coronary artery disease (CAD), number and function of endothelial progenitor cells (EPCs) are down-regulated. The relevant intracellular signalling mechanisms responsible for dysfunction of EPCs in CAD remain poorly characterized. Our goal was to examine the regulation of ERK-1/2 by SDF-1 and the role of ERK-1/2 for adhesion in EPCs. Western analysis revealed that the chemokine SDF-1 (SDF-1, 100 nM) mediates phosphorylation of ERK-2 after 90 s with a maximum after 180-300 s in EPCs isolated from healthy control subjects, while EPCs from patients with CAD are characterized by a temporally delayed and quantitatively markedly attenuated SDF-1-triggered ERK-2-phosphorylation. Functionally, EPCs isolated from patients with CAD display reduced SDF-1-induced adhesion under flow conditions, while augmenting ERK-2 signalling using an activating MEK-2 cDNA construct restores adhesion to control levels and rescues the adhesion defect of CAD-EPCs. These data indicate that defects in SDF-1-triggered EPC-adhesion contribute to the functional impairment of EPCs in CAD, and that ERK-2 represents a new therapeutic target for functional improvement of EPC adhesion in CAD.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19363666     DOI: 10.1007/s00395-009-0022-6

Source DB:  PubMed          Journal:  Basic Res Cardiol        ISSN: 0300-8428            Impact factor:   17.165


  7 in total

1.  Incremental increase in VEGFR1⁺ hematopoietic progenitor cells and VEGFR2⁺ endothelial progenitor cells predicts relapse and lack of tumor response in breast cancer patients.

Authors:  Sarika Jain; Maureen M Ward; Jennifer O'Loughlin; Marissa Boeck; Naomi Wiener; Ellen Chuang; Tessa Cigler; Anne Moore; Diana Donovan; Christina Lam; Marta V Cobham; Sarah Schneider; Paul Christos; Rebecca N Baergen; Alexander Swistel; Maureen E Lane; Vivek Mittal; Shahin Rafii; Linda T Vahdat
Journal:  Breast Cancer Res Treat       Date:  2011-12-09       Impact factor: 4.872

2.  Angiotensin II-derived reactive oxygen species promote angiogenesis in human late endothelial progenitor cells through heme oxygenase-1 via ERK1/2 and AKT/PI3K pathways.

Authors:  Jingting Mai; Qiong Qiu; Yong Qing Lin; Nian Sang Luo; Hai Feng Zhang; Zhu Zhi Wen; Jing Feng Wang; Chen YangXin
Journal:  Inflammation       Date:  2014-06       Impact factor: 4.092

Review 3.  Hematopoietic cytokines for cardiac repair: mobilization of bone marrow cells and beyond.

Authors:  Santosh K Sanganalmath; Ahmed Abdel-Latif; Roberto Bolli; Yu-Ting Xuan; Buddhadeb Dawn
Journal:  Basic Res Cardiol       Date:  2011-05-04       Impact factor: 17.165

4.  Opposing effects of monomeric and pentameric C-reactive protein on endothelial progenitor cells.

Authors:  I Ahrens; H Domeij; S U Eisenhardt; D Topcic; M Albrecht; E Leitner; K Viitaniemi; J B Jowett; M Lappas; C Bode; I Haviv; K Peter
Journal:  Basic Res Cardiol       Date:  2011-05-12       Impact factor: 17.165

5.  Relationship of Circulating CXCR4+ EPC with Prognosis of Mild Traumatic Brain Injury Patients.

Authors:  Yunpeng Lin; Lan Lan Luo; Jian Sun; Weiwei Gao; Ye Tian; Eugene Park; Andrew Baker; Jieli Chen; Rongcai Jiang; Jianning Zhang
Journal:  Aging Dis       Date:  2017-02-01       Impact factor: 6.745

6.  Activation of ATP-sensitive potassium channels facilitates the function of human endothelial colony-forming cells via Ca2+ /Akt/eNOS pathway.

Authors:  Yan Wu; Meng-Yu He; Jian-Kui Ye; Shu-Ying Ma; Wen Huang; Yong-Yue Wei; Hui Kong; Hong Wang; Xiao-Ning Zeng; Wei-Ping Xie
Journal:  J Cell Mol Med       Date:  2016-10-06       Impact factor: 5.310

7.  Effect of Combined Use of Astragaloside IV (AsIV) and Atorvastatin (AV) on Expression of PPAR-γ and Inflammation-Associated Cytokines in Atherosclerosis Rats.

Authors:  Bin Sun; Ruping Rui; Haiying Pan; Luchang Zhang; Xiaolong Wang
Journal:  Med Sci Monit       Date:  2018-09-07
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.